We provide you with 20 years of free, institutional-grade data for ATAI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ATAI. Explore the full financial landscape of ATAI stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about ATAI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ATAI Life Sciences(NASDAQ:ATAI) 
atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Headquartered in Berlin, with offices
Website: https://www.atai.life/
Founded: 2018
IPO Price: $15 (Jun 18, 2021)
Full Time Employees: 101
Sector: Consumer Defensive
Industry: Education & Training Services